banner
IAP antagonist SM-164, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ116

IAP antagonist SM-164, Purity ≥98%

Synonym: 957135-43-2; SM-164; SM164; G2VA4GC8KB; SM-164 (pharmaceutical); UNII-G2VA4GC8KB; (3S,3'S,6S,6'S,10aS,10a'S)-N,N'-((1S,1'S)-((1,4-Phenylenebis(butane-4,1-diyl))bis(1H-1,2,3-triazole-1,4-diyl))bis(phenylmethylene))bis(6-((S)-2-(methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide); IAP antagonist

  • CAS Number: 957135-43-2
  • Compound CID: 17756618
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SM-164, soluble in DMSO and insoluble in ethanol and water, is a molecule designed to neutralize the function of IAPs, thereby promoting apoptosis, especially in cancer cells.
Molecular Weight
1121.42
Molecular Formula
C62H84N14O6
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 3 mg/mL (2.67 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
SM-164 is investigated for its role as an IAP antagonist inducing apoptosis in cancer cell research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0